In this study, the authors showed that the GPC3-targeting immunotoxin HN3-mPE24 induced potent cytotoxicity in GPC3-positive hepatocellular carcinoma (HCC) cells, confirming its therapeutic potential. Here, GPC3 is linked to hepatocellular carcinoma.